Natko Pharma continues today

Stock markets climb a series of Natko Pharma continues today. Bombay Stock Exchange (BSE) in today’s business went to jumping to 132.20 rupees, which most of its 52-week high level. However, its decline is a bit of an edge and in the morning at 11.20 to 128.60 rupees on the stock price is up 4.05%. In yesterday’s trading at BSE Pharma BSE Natko with 20% of the boom was closed at Rs 123.60. In the last two days, yet the stock has climbed more than 24.8%.

Stock markets close of business Monday after the company reported that its partner company Maylan Inc. Glatiramr injections (20 mg / ml) for the U.S. Food and Drug Administration (U.S. FDA) has approved the Aandia. The drug generic form of Kopakson the Tewa. This medication is used in the treatment of Multiple Sclerosis and the year 2009 global sales of the drug is expected to be approximately $ 3 billion.

The company last year, Pittsburgh Natko Pharma Inc. with a license and supply agreement Maylan did.

No related posts.